UNK TISSUE EXPANDER
Report
- Report Number
- 9617229-2022-10279
- Event Type
- Injury
- Date Received
- June 6, 2022
- Report Date
- June 6, 2022
- Manufacturer
- ALLERGAN (COSTA RICA)
- Product Code
- LCJ
- PMA / PMN Number
- K862203
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- JA
- Reporter Occupation
- PHYSICIAN
- Health Professional
- Yes
Narratives
ARTICLE CITATION: SATOKO ONISHI, YOSHIKAZU INOUE, MAKI INUKAI, TAKAYUKI OKUMOTO, PREVENTING INFECTION AFTER SYNTHETIC EXPANDER IMPLANTATION IN PATIENTS UNDERGOING BREAST RECONSTRUCTION, FUJITA MEDICAL JOURNAL, 2022, VOLUME 8, ISSUE 2, PAGES 42-45, RELEASED ON J-STAGE MAY 01, 2022, ADVANCE ONLINE PUBLICATION AUGUST 20, 2021, ONLINE ISSN 2189-7255, PRINT ISSN 2189-7247, HTTPS://DOI.ORG/10.20407/FMJ.2020-029, HTTPS://WWW.JSTAGE.JST.GO.JP/ARTICLE/FMJ/8/2/8_2020-029/_ARTICLE/-CHAR/EN. THE EVENT OF INFECTION IS A PHYSIOLOGICAL COMPLICATION AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THIS EVENT. FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT, PRODUCT, OR PATIENT DETAILS HAS BEEN REQUESTED. NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME. REASON FOR REOPERATION: INFECTION.
THROUGH JOURNAL ARTICLE "PREVENTING INFECTION AFTER SYNTHETIC EXPANDER IMPLANTATION IN PATIENTS UNDERGOING BREAST RECONSTRUCTION" IT WAS REPORTED PATIENT "WITH AN INFECTION HAD A SKIN ULCER AT THE POSTOPERATIVE WOUND SITE. IT WAS TREATED CONSERVATIVELY WITH OINTMENT, AND THE WOUND STABILIZED. CHEMOTHERAPY WAS STARTED 1 MONTH POSTOPERATIVELY, AFTER WHICH INFLAMMATORY FINDINGS, INCLUDING CHEST ERYTHEMA, AND FEVER WERE OBSERVED. TREATMENT WITH INTRAVENOUS ANTIBIOTICS WAS UNSUCCESSFUL, AND THE IMPLANT WAS REMOVED. (B)(6) WAS ISOLATED FROM CULTURES OF THE WOUND SITE SPECIMEN THAT HAD BEEN COLLECTED INTRAOPERATIVELY."
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 215279 | UNK TISSUE EXPANDER | EXPANDER, SKIN, INFLATABLE | LCJ | ALLERGAN (COSTA RICA) | NI |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Female | Required Intervention |